General Archive
![](https://www.lifearc.org/wp-content/uploads/2024/01/image-1.png)
-
News releases, Ventures funding
LifeArc invests £1.5 million in Ducentis BioTherapeutics
LifeArc’s Seed Fund has invested £1.5 million in Ducentis BioTherapeutics to develop novel drug therapies for inflammatory and autoimmune disease